3 New Strong Buy Ratings from Top-Rated Analysts: 02/26/2026
Just for you — a no-paywall peek at our Strong Buy Stocks from Top Wall Street Analysts screener:
- Diebold Nixdorf (DBD) — Up over 130% and still climbing post-restructuring
- Tactile Systems Technology (TCMD) — 234% surge fueled by chronic disease device demand
- Element Solutions (ESI) — Semiconductor boom powers 56% earnings growth
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Buffett's $114 Secret In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account." Today, that single, $114 investment would be worth over $15 million. Your bank never told you about this. Click Here to See How It Works1. Tactile Systems Technology (NASDAQ: TCMD)
Tactile Systems Technology is gaining momentum in the chronic disease treatment market. With shares up 234% from their 52-week low and projected earnings growth of 23%, the maker of the Flexitouch Plus system is expanding its footprint in an underserved space. Here’s why investors are taking notice.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $28.65 — get current quote
Max 1-year forecast: $42.00
Why we're watching:
- Analyst support: TCMD has Strong Wall Street endorsement with 3 Strong Buy ratings and 1 Hold rating from 4 covering analysts following the stock. See the ratings
- BTIG's Ryan Zimmerman (a top 11% rated analyst) recently maintained his Strong Buy rating with a $38 price target, detailing the strong demand for TCMD's products and competitive advantages in a growing market.
- Piper Sandler's Adam Maeder maintained his Strong Buy rating with the Street-high $42 price target, providing in-depth analysis of market factors influencing share price and emphasizing the company's strong growth projections and market position.
- Industry ranking context: TCMD is currently the 3rd highest-rated stock in the Medical Device industry, which has an Industry Rating of C.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — TCMD demonstrates balanced strength across several key areas as revealed by the 7 Component Grades that shape the overall rating (breakdown below).
- Component Grades: Financials scores an outstanding A rating with strong profit margins of 10.3% and excellent asset efficiency, while Value, Growth, and Momentum all earn solid B grades reflecting well-rounded fundamentals. (See all 7 Zen Component Grades here)
2. Element Solutions (NYSE: ESI)
Element Solutions is riding strong demand in semiconductor and industrial markets. With shares up 111% from their 52-week low and earnings growth of 56%, the specialty chemicals maker is delivering both performance and momentum. Here’s why it stands out.
Zen Rating: B (Buy) — see full analysis
Recent Price: $36.48 — get current quote
Max 1-year forecast: $43.00
Why we're watching:
- Analyst support: Overwhelming Wall Street support with 5 Strong Buy ratings and 2 Buy ratings from 7 covering analysts following Q4 results that surpassed estimates. See the ratings
- Mizuho's John Roberts (a top 5% rated analyst) recently maintained his Buy rating with a $35 price target, highlighting the company's exposure to favorable secular trends in electronics.
- KeyBanc researcher Aleksey Yefremov (a top 19% rated analyst) maintained his Strong Buy rating with a $36 price target following strong quarterly results and improved full-year guidance.
- Industry ranking context: ESI is currently the 4th highest-rated stock in the Specialty Chemical industry, which has an Industry Rating of B.
- Zen Rating highlights: Buy (B) stocks average +19.88%/yr — putting ESI in a class of stocks that has historically outperformed the S&P.
- Component Grades: Safety achieves an elite A rating reflecting the company's strong balance sheet with manageable debt-to-equity of 0.9, while Momentum earns a B grade indicating sustained positive price trends. (See all 7 Zen Component Grades here)
3. Diebold Nixdorf (NYSE: DBD)
Diebold Nixdorf is rapidly redefining its position in the global banking technology market. With shares up 133% from their 52-week low and earnings surging 91%, the company’s post-restructuring transformation is gaining real traction. As digital banking accelerates worldwide, Diebold Nixdorf is not just recovering — it’s capturing market share and building momentum. Here’s why investors are paying attention.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $80.70 — get current quote
Max 1-year forecast: $100.00
Why we're watching:
- Analyst support: Solid Wall Street backing with 1 Strong Buy rating and 1 Buy rating from 2 covering analysts, reflecting confidence in the company's turnaround story. See the ratings
- Following Q4 earnings that topped estimates, several analysts have raised forecasts, highlighting the company's successful navigation of its Chapter 11 emergence and renewed focus on core banking and retail technology solutions.
- For example, DA Davidson's Matt Summerville (a top 7% rated analyst) recently maintained his Strong Buy rating with a $100 price target, believing Diebold Nixdorf is positioned well to capitalize on market opportunities with projected strong earnings growth and operational efficiencies expected to drive profitability.
- Industry ranking context: DBD is currently the 1st highest-rated stock in the App industry, which has an Industry Rating of B.
- Zen Rating highlights: DBD earns a Strong Buy or A rating from our quant ratings system — an elite tier of tickers that have historically averaged +32.52%/yr
- Component Grades: Growth achieves an outstanding A rating alongside Sentiment also at A, while Value earns a solid B grade and Financials scores A, demonstrating the company's improving financial profile post-restructuring. (See all 7 Zen Component Grades here)
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.